KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment?

Federica Grillo, Luca Valle, Diego Ferone, Manuela Albertelli, Maria Pia Brisigotti, Giuseppe Cittadini, Alessandro Vanoli, Roberto Fiocca, Luca Mastracci

Research output: Contribution to journalArticle

Abstract

Purpose: Ki-67 heterogeneity can impact on gastroenteropancreatic neuroendocrine tumor grade assignment, especially when tissue is scarce. This work is aimed at devising adequacy criteria for grade assessment in biopsy specimens. Method: To analyze the impact of biopsy size on reliability, 360 virtual biopsies of different thickness and lengths were constructed. Furthermore, to estimate the mean amount of non-neoplastic tissue component present in biopsies, 28 real biopsies were collected, the non-neoplastic components (fibrosis and inflammation) quantified and the effective area of neoplastic tissue calculated for each biopsy. Results: Heterogeneity of Ki-67 distribution, G2 tumors and biopsy size all play an important role in reducing the reliability of biopsy samples in Ki-67-based grade assignment. In particular in G2 cases, 59.9% of virtual biopsies downgraded the tumor and the smaller the biopsy, the more frequent downgrading occurs. In real biopsies the presence of non-neoplastic tissue reduced the available total area by a mean of 20%. Conclusions: By coupling the results from these two different approaches we show that both biopsy size and non-neoplastic component must be taken into account for biopsy adequacy. In particular, we can speculate that if the minimum biopsy area, necessary to confidently (80% concordance) grade gastro-entero-pancreatic neuroendocrine tumors on virtual biopsies ranges between 15 and 30 mm2, and if real biopsies are on average composed of only 80% of neoplastic tissue, then biopsies with a surface area not <12 mm2 should be performed; using 18G needles, this corresponds to a minimum total length of 15 mm.

Original languageEnglish
Pages (from-to)494-502
Number of pages9
JournalEndocrine
Volume57
Issue number3
DOIs
Publication statusPublished - Sep 1 2017

Fingerprint

Neuroendocrine Tumors
Biopsy

Keywords

  • Biopsy
  • Gastroenteropancreatic neuroendocrine tumors
  • Grade
  • Ki-67

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors : when is biopsy reliable for grade assessment? / Grillo, Federica; Valle, Luca; Ferone, Diego; Albertelli, Manuela; Brisigotti, Maria Pia; Cittadini, Giuseppe; Vanoli, Alessandro; Fiocca, Roberto; Mastracci, Luca.

In: Endocrine, Vol. 57, No. 3, 01.09.2017, p. 494-502.

Research output: Contribution to journalArticle

@article{31adabbccfdc4d9b85aa003bccc3bb0e,
title = "KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment?",
abstract = "Purpose: Ki-67 heterogeneity can impact on gastroenteropancreatic neuroendocrine tumor grade assignment, especially when tissue is scarce. This work is aimed at devising adequacy criteria for grade assessment in biopsy specimens. Method: To analyze the impact of biopsy size on reliability, 360 virtual biopsies of different thickness and lengths were constructed. Furthermore, to estimate the mean amount of non-neoplastic tissue component present in biopsies, 28 real biopsies were collected, the non-neoplastic components (fibrosis and inflammation) quantified and the effective area of neoplastic tissue calculated for each biopsy. Results: Heterogeneity of Ki-67 distribution, G2 tumors and biopsy size all play an important role in reducing the reliability of biopsy samples in Ki-67-based grade assignment. In particular in G2 cases, 59.9{\%} of virtual biopsies downgraded the tumor and the smaller the biopsy, the more frequent downgrading occurs. In real biopsies the presence of non-neoplastic tissue reduced the available total area by a mean of 20{\%}. Conclusions: By coupling the results from these two different approaches we show that both biopsy size and non-neoplastic component must be taken into account for biopsy adequacy. In particular, we can speculate that if the minimum biopsy area, necessary to confidently (80{\%} concordance) grade gastro-entero-pancreatic neuroendocrine tumors on virtual biopsies ranges between 15 and 30 mm2, and if real biopsies are on average composed of only 80{\%} of neoplastic tissue, then biopsies with a surface area not <12 mm2 should be performed; using 18G needles, this corresponds to a minimum total length of 15 mm.",
keywords = "Biopsy, Gastroenteropancreatic neuroendocrine tumors, Grade, Ki-67",
author = "Federica Grillo and Luca Valle and Diego Ferone and Manuela Albertelli and Brisigotti, {Maria Pia} and Giuseppe Cittadini and Alessandro Vanoli and Roberto Fiocca and Luca Mastracci",
year = "2017",
month = "9",
day = "1",
doi = "10.1007/s12020-017-1364-8",
language = "English",
volume = "57",
pages = "494--502",
journal = "Endocrine",
issn = "1355-008X",
publisher = "Humana Press Inc.",
number = "3",

}

TY - JOUR

T1 - KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors

T2 - when is biopsy reliable for grade assessment?

AU - Grillo, Federica

AU - Valle, Luca

AU - Ferone, Diego

AU - Albertelli, Manuela

AU - Brisigotti, Maria Pia

AU - Cittadini, Giuseppe

AU - Vanoli, Alessandro

AU - Fiocca, Roberto

AU - Mastracci, Luca

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Purpose: Ki-67 heterogeneity can impact on gastroenteropancreatic neuroendocrine tumor grade assignment, especially when tissue is scarce. This work is aimed at devising adequacy criteria for grade assessment in biopsy specimens. Method: To analyze the impact of biopsy size on reliability, 360 virtual biopsies of different thickness and lengths were constructed. Furthermore, to estimate the mean amount of non-neoplastic tissue component present in biopsies, 28 real biopsies were collected, the non-neoplastic components (fibrosis and inflammation) quantified and the effective area of neoplastic tissue calculated for each biopsy. Results: Heterogeneity of Ki-67 distribution, G2 tumors and biopsy size all play an important role in reducing the reliability of biopsy samples in Ki-67-based grade assignment. In particular in G2 cases, 59.9% of virtual biopsies downgraded the tumor and the smaller the biopsy, the more frequent downgrading occurs. In real biopsies the presence of non-neoplastic tissue reduced the available total area by a mean of 20%. Conclusions: By coupling the results from these two different approaches we show that both biopsy size and non-neoplastic component must be taken into account for biopsy adequacy. In particular, we can speculate that if the minimum biopsy area, necessary to confidently (80% concordance) grade gastro-entero-pancreatic neuroendocrine tumors on virtual biopsies ranges between 15 and 30 mm2, and if real biopsies are on average composed of only 80% of neoplastic tissue, then biopsies with a surface area not <12 mm2 should be performed; using 18G needles, this corresponds to a minimum total length of 15 mm.

AB - Purpose: Ki-67 heterogeneity can impact on gastroenteropancreatic neuroendocrine tumor grade assignment, especially when tissue is scarce. This work is aimed at devising adequacy criteria for grade assessment in biopsy specimens. Method: To analyze the impact of biopsy size on reliability, 360 virtual biopsies of different thickness and lengths were constructed. Furthermore, to estimate the mean amount of non-neoplastic tissue component present in biopsies, 28 real biopsies were collected, the non-neoplastic components (fibrosis and inflammation) quantified and the effective area of neoplastic tissue calculated for each biopsy. Results: Heterogeneity of Ki-67 distribution, G2 tumors and biopsy size all play an important role in reducing the reliability of biopsy samples in Ki-67-based grade assignment. In particular in G2 cases, 59.9% of virtual biopsies downgraded the tumor and the smaller the biopsy, the more frequent downgrading occurs. In real biopsies the presence of non-neoplastic tissue reduced the available total area by a mean of 20%. Conclusions: By coupling the results from these two different approaches we show that both biopsy size and non-neoplastic component must be taken into account for biopsy adequacy. In particular, we can speculate that if the minimum biopsy area, necessary to confidently (80% concordance) grade gastro-entero-pancreatic neuroendocrine tumors on virtual biopsies ranges between 15 and 30 mm2, and if real biopsies are on average composed of only 80% of neoplastic tissue, then biopsies with a surface area not <12 mm2 should be performed; using 18G needles, this corresponds to a minimum total length of 15 mm.

KW - Biopsy

KW - Gastroenteropancreatic neuroendocrine tumors

KW - Grade

KW - Ki-67

UR - http://www.scopus.com/inward/record.url?scp=85025088230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025088230&partnerID=8YFLogxK

U2 - 10.1007/s12020-017-1364-8

DO - 10.1007/s12020-017-1364-8

M3 - Article

AN - SCOPUS:85025088230

VL - 57

SP - 494

EP - 502

JO - Endocrine

JF - Endocrine

SN - 1355-008X

IS - 3

ER -